Drug Trial Radar · NCT04959331
Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.
Last checked: Nov 19, 2026Latest source record: Sep 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,000
Actual
Start
Nov 2, 2021
Primary completion
Dec 14, 2024
Study completion Dec 31, 2024
Sponsor
- Lead sponsor
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Balearic Islands Health Service (Ibsalut); Instituto de Investigación Sanitaria Aragón; Gerencia de Atención Primaria, Madrid
- First posted
- Jul 13, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Randomized clinical trial in which women aged 18 or older and with symptoms of uncomplicated lower urinary tract infection and a positive urine dipstick analysis will be randomized to one of the following four groups: 2-day 3 g fosfomycin o.d., 3-day pivmecillinam 400 mg. t.i.d, 5-day nitrofurantoin 100 mg t.i.d. or a single dose of 3 g of fosfomycin. Sample: 1,000 patients. Two co-primary endpoints are considered: clinical effectiveness at day 7 and bacteriological eradication at day 14. Follow-up visits are scheduled at days 7 (phone call), 14 and 28 for assessing evolution. Urine samples will be collected in the three on-site visits and urine cultures performed.
Conditions
- Urinary Tract Infections
Interventions
Fosfomycin Trometamol SaltDrug
Fosfomycin 3 g 2 sachets, taken orally, once daily for two days
NitrofurantoinDrug
Nitrofurantoin 50 mg pills, taken orally, two pills/8 hours, for five days
PivmecillinamDrug
Pivmecillinam 400 mg pills. taken orally, one pill/8 hours, for three days
Fosfomycin Trometamol SaltDrug
Fosfomycin 3 g one sachet, taken orally, for one day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical effectiveness.Time frame: Day 7.
- Bacteriological eradication.Time frame: Day 14.
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Calatayud Center
Calatayud, Aragon, Spain
Las Fuentes Center
Zaragoza, Aragon, Spain
Arrabal Health Center
Zaragoza, Aragon, Spain
Parque Goya Health Center
Zaragoza, Aragon, Spain
Santa Ponça Health Center
Calvià, Balearic Islands, Spain
Emili Darder Center
Palma de Mallorca, Balearic Islands, Spain
Camp Redó Health Center
Palma de Mallorca, Balearic Islands, Spain
Son Pisà Center
Palma de Mallorca, Balearic Islands, Spain
Son Serra-La Vileta Health Center
Palma de Mallorca, Balearic Islands, Spain
Santa Maria del Camí Center
Santa Maria del Camí, Balearic Islands, Spain
Banyoles Center
Banyoles, Catalonia, Spain
Corbera Center
Corbera de Llobregat, Catalonia, Spain
La Gavarra Health Center
Cornellà de Llobregat, Catalonia, Spain
17 de Setembre Center
el Prat de Llobregat, Catalonia, Spain
Can Vidalet Center
Esplugues de Llobregat, Catalonia, Spain
Santa Clara Center
Girona, Catalonia, Spain
Florida Center
L'Hospitalet de Llobregat, Catalonia, Spain
Can Serra Center
L'Hospitalet de Llobregat, Catalonia, Spain
Montblanc Center
Montblanc, Catalonia, Spain
Pere Garau Center
Palma de Mallorca, Catalonia, Spain
Molí Nou Center
Sant Boi de Llobregat, Catalonia, Spain
Sant Feliu de Guíxols Center
Sant Feliu de Guíxols, Catalonia, Spain
Sant Just Desvern Center
Sant Just Desvern, Catalonia, Spain
Vila Vella Center
Sant Vicenç dels Horts, Catalonia, Spain
Jaume I Health Center
Tarragona, Catalonia, Spain
El Puerto Center
Coslada, Madrid, Spain
Valleaguado Health Center
Coslada, Madrid, Spain
Los Alpes Health Center
Madrid, Madrid, Spain
Aquitania Health Center
Madrid, Madrid, Spain
Mar Báltico Center
Madrid, Madrid, Spain
Buenos Aires Center
Madrid, Madrid, Spain
San Fernando Health Center
San Fernando de Henares, Madrid, Spain
Villarejo de Salvanés Health Center
Villarejo de Salvanés, Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.